Bausch Health
BHC
#3607
Rank
A$4.50 B
Marketcap
$12.27
Share price
2.00%
Change (1 day)
3.46%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Bausch Health (BHC) - Total debt

Total debt on the balance sheet as of June 2024 : A$32.48 B

According to Bausch Health 's latest financial reports the company's total debt is A$32.48 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Bausch Health - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2023-12-31A$32.86 B7.68%
2022-12-31A$30.51 B-2.06%
2021-12-31A$31.15 B0.35%
2020-12-31A$31.04 B-15.71%
2019-12-31A$36.83 B6.81%
2018-12-31A$34.48 B5.82%
2017-12-31A$32.59 B-21.29%
2016-12-31A$41.40 B-3.03%
2015-12-31A$42.70 B129.83%
2014-12-31A$18.57 B-4.65%
2013-12-31A$19.48 B83.22%
2012-12-31A$10.63 B63.95%
2011-12-31A$6.48 B77.91%
2010-12-31A$3.64 B731.27%
2009-12-31A$0.43 B375.56%
2008-12-31A$92.23 M
2006-12-31A$0.52 B-12.77%
2005-12-31A$0.59 B-3.53%
2004-12-31A$0.61 B-43.38%
2003-12-31A$1.09 B-17.59%
2002-12-31A$1.32 B1366.56%
2001-12-31A$90.44 M-93.15%
2000-12-31A$1.32 B531.41%
1999-12-31A$0.20 B0.97%
1998-12-31A$0.20 B2655.6%
1997-12-31A$7.52 M-14.65%
1996-12-31A$8.81 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.40 B-98.76%๐Ÿ‡บ๐Ÿ‡ธ USA